Custom Antibody Market Size & Share to Surpass $1.2 Billion by 2030 | Vantage Market Research

| Source: Vantage Market Research Vantage Market Research

WASHINGTON, July 28, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Custom Antibody Market has been steadily growing over the years due to the rising demand for individualized and focused treatments across many specialties, including immunology, oncology, and infectious diseases. Custom antibodies are extremely useful for research, diagnostics, and therapeutics because of their superior specificity, sensitivity, and adaptability.

According to Vantage Market Research, the global Custom Antibody Market is estimated to be valued at USD 1.2 billion by 2030 and is expected to exhibit a CAGR of 9.75% during the forecast period 2023 to 2030. The global Custom Antibody Market grew to USD 0.61 billion in 2022.

An antibody that is specifically created and produced to target a particular antigen or protein of interest is referred to as a Custom Antibody. It has many uses, including therapeutics, research, and diagnostics. Through the selective detection, isolation, and study of particular molecules in biological samples, custom antibodies help researchers better understand a variety of diseases and accelerate the creation of targeted treatments.

To Get Additional Highlights on Major Revenue-Generating Segments, Request a Custom Antibody Market Sample Report at@ https://www.vantagemarketresearch.com/custom-antibody-market-2201/request-sample

Key Highlights

  • By Type, in 2022, monoclonal antibodies accounted for 50% of the market for custom antibodies and the market's fastest-growing subsegment is recombinant antibodies. It is anticipated to grow at a CAGR of 11% from 2023 to 2030.
  • By Service, between 2023 and 2030, antibody production and development are anticipated to grow fastest.
  • By Source, in 2022, the mice category dominated the market.
  • By Application, the diagnostics category is expected to grow at the highest CAGR during 2023-2030.
  • North America held a 44% market share for custom antibodies in 2022.

The Custom Antibody market is essential for numerous applications in numerous industries. Custom antibodies are used in the medical field for therapeutic treatments, cancer research, diagnostic tests, and personalized medicine. They assist in the early detection and management of disease by identifying particular proteins, biomarkers, and pathogens. Custom antibodies are used in the agricultural industry to protect crops and check for harmful ingredients in food products. Custom antibodies are also used in the environmental and forensic fields to monitor pollution, conduct forensic analyses, and identify environmental contaminants. Custom antibodies have numerous uses, which highlights their importance for advancing research and diagnostics as well as enhancing human and environmental health.

Factors Affecting the Growth of the Custom Antibody Market

There are several factors that can affect the growth of the Custom Antibody Market Some of these factors include:

  • Chronic diseases are becoming more common: The demand for custom antibodies is being fueled by the increasing prevalence of chronic diseases like cancer, infectious diseases, and autoimmune disorders. Targeted and particular antibodies are rapidly being developed as a result of the need for personalized treatments for these diseases.
  • Technology advancements in antibody production: The production of specialized antibodies has become easier and faster thanks to developments in phage display, recombinant DNA, and hybridoma technology. These technologies allow for the effective creation of antibody libraries that are tailored to particular targets, which expands the market.
  • Growing life sciences research: There is a significant market for custom antibodies as a result of the growing research in fields like genomics, proteomics, and personalized medicine. Specific antibodies are needed by researchers for numerous applications, such as Western blotting, flow cytometry, immunohistochemistry, and drug discovery, which is fueling market expansion.
  • Increasing investments in biotechnology and pharmaceutical firms: As a result of rising investments in the biotechnology and pharmaceutical industries, there is an increasing emphasis on the creation of novel therapeutics and diagnostics. These developments depend heavily on custom antibodies, which raises consumer demand.
  • Growth of contract research organizations (CROs): The number of CROs providing Custom Antibody services has increased, which has significantly boosted market expansion. For researchers and pharmaceutical companies, outsourcing Custom Antibody production to specialized CROs offers affordable and high-quality solutions, driving market expansion.

To Understand How Our Report Can Bring a Difference to Your Business Strategy, Inquire About a Brochure at@ https://www.vantagemarketresearch.com/custom-antibody-market-2201/inquiry-before-buying

Report Scope

Report AttributeDetails
Market Value (2022)USD 0.61 Billion
Market Size (2030)USD 1.2 Billion
CAGR (from 2023 to 2030)9.8%
North America Revenue Share44%
Historic Period2018 to 2021
Base Year2022 
Forecast Year2023 to 2030

Top Trends in Global Custom Antibody Market

Significant trends are influencing the Custom Antibody market globally and are changing the market. One of the most prominent trends is the rise in personalized medicine, which has stimulated the production of custom antibodies. Additionally, the development of antibodies has been transformed by technological advances such as genomics and next-generation sequencing, which provide more precise and effective solutions. Furthermore, a booming market for customized antibody treatments has been produced by the rising prevalence of chronic diseases and the expanding use of targeted therapy.

Regional Analysis

North America dominates the market, and this trend of dominance will continue throughout the projection period. Government organizations that offer grants and support for antibody research and development include the National Institutes of Health (NIH) in the United States and the Canadian Institutes of Health Research (CIHR) in Canada. Government regulations also guarantee the production and distribution of custom antibodies with regard to quality assurance, security, and moral behavior. The development and growth of the Custom Antibody market in North America are greatly influenced by these government initiatives. Additionally, factors like the presence of many key players, well-developed research infrastructure, and increasing R&D investments drive increased demand for Custom Antibody in this region. Additionally, the Custom Antibody market is expanding at the fastest rate in the Asia-Pacific region. The demand for custom antibodies in this region is being fueled by factors like rising research and development expenditures, rising personalized medicine adoption, and expanding biotechnology and pharmaceutical sectors.

Enjoy a Fabulous 50% Discount with Code "JULY50"! Don't Miss Out on These Incredible Savings@ https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Market Drivers

The prevalence of chronic diseases like cancer and autoimmune disorders is increasing, which is one of the factors driving the global market for custom antibodies. Additionally, the market is expanding due to the rising demand for targeted therapies and personalized medicine. Custom antibodies with improved specificity and sensitivity have also been made possible by improvements in antibody production technologies like recombinant DNA technology and hybridoma technology. Additionally, the market is growing as custom antibodies are being used more frequently in diagnostics, therapeutics, and research.

Market Restraints

The high cost associated with creating and manufacturing customized antibodies is a significant restraint on the Custom Antibody market. The process of creating a Custom Antibody can be time-consuming and costly, and it calls for specialized knowledge, tools, and materials. The cost of customization is further increased by the frequent use of trial-and-error iterations. Many scientists and organizations, especially those with limited funding, are discouraged from purchasing custom antibodies as a result of these factors.

Market Opportunities

The Custom Antibody market has a huge and bright future ahead of it. There is an increasing need for personalized antibodies to target particular diseases and biomarkers as a result of developments in biotechnology and personalized medicine. It is anticipated that the use of machine learning and artificial intelligence in antibody development will streamline the procedure and increase its effectiveness and efficiency. Additionally, the growth of the market is likely to be fueled by an increase in government funding for healthcare-related research and development, which will make it possible to produce highly specialized antibodies for a variety of therapeutic uses. Future Custom Antibody production is expected to rely heavily on automation. The industry will witness the growth of automated technologies for producing, separating, and describing antibodies.

Grow Your Profit Margin with Vantage Market Research - Purchase This Premium Report at: https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Report Segmentation of the Global Custom Antibody Market

Type Analysis
Due to a number of factors, monoclonal antibodies (mAbs) currently rule the Custom Antibody market. First off, mAbs are perfect for a variety of research applications due to their high specificity and binding affinity. Additionally, they are highly sought-after for personalized medicine due to their simplicity in being tailored to target particular antigens. Their dominance is also aided by the vast knowledge and well-established protocols surrounding the production of monoclonal antibodies. Additionally, improvements in hybridoma technology and recombinant DNA techniques have increased the productivity and cost-effectiveness of mAb production, which has increased their market share.

Service Analysis
For a number of reasons, the market for custom antibodies is dominated by the antibody production and development segment. First off, there is a high demand for custom-made antibodies due to the crucial role that antibodies play in biological research, diagnostics, and therapeutic applications. Technology and genetic engineering advancements have also made it possible to produce highly specific antibodies that are specifically designed for different applications. Additionally, the ability to modify antibodies to meet the precise needs of scientists and medical professionals increases their usefulness and potency in a variety of fields, including immunology, oncology, and infectious diseases. These elements play a part in the Antibody Production and Development segment's dominance of the Custom Antibody market.

Source Analysis
The Custom Antibody market is dominated by mouse segments for a number of reasons. First off, mice are excellent for producing antibodies because they are highly compatible with human immune systems. Second, because of their sophisticated immune systems, mice are more likely to develop custom antibodies because they can produce a wider variety of antibodies. Mice are also more affordable for mass production, which makes them popular with scientists and businesses. Thus, the mice segment dominates the market for custom antibodies due to their compatibility, diverse antibody generation, and affordability.

Application Analysis
The Custom Antibody market is dominated by the diagnostic segment for a number of reasons. First off, the demand for custom antibodies in diagnostic applications has been fueled by the rising prevalence of chronic diseases and the need for reliable diagnostic tools. Second, the creation and use of custom antibodies for disease detection with higher sensitivity and specificity have been made possible by technological advancements and the accessibility of sophisticated diagnostic platforms. The demand for custom antibodies in diagnostics to identify particular biomarkers for disease diagnosis and treatment has also increased as a result of the growing emphasis on personalised medicine and targeted therapies.

End-User Analysis
The Custom Antibody market is dominated by pharmaceutical and biotechnology companies for a variety of factors. First off, they have a wealth of resources and experience in research and development, which allows them to create innovative and high-quality antibodies. Second, their access to cutting-edge technology makes efficient customization and mass production possible. These businesses frequently collaborate with research organisations and academic institutions, which facilitates knowledge exchange and expands their capabilities. In the end, their dominance in the market is due to their capacity to deliver customised solutions that specifically address the needs of researchers and clinicians.

For More Insights on the Historical and Forecast Market Data From 2023 to 2030 - Download a Sample Report at: https://www.vantagemarketresearch.com/custom-antibody-market-2201/request-sample

Competitive Landscape

The market for custom antibodies is experiencing fierce competition as a result of the rising demand for personalized medicine and biotechnology advancements. To gain a competitive edge, major market players are implementing tactics like mergers, acquisitions, and collaborations. For instance, to increase its capabilities in the antibody production market, Thermo Fisher Scientific recently acquired Novasep's viral vector manufacturing business. Another noteworthy development is Abcam's collaboration with Visikol to provide full custom multiplexed antibody services, enabling researchers to simultaneously study numerous protein targets. These developments demonstrate the market's dynamism and the ongoing efforts of businesses to offer distinctive and effective Custom Antibody solutions.

  • Thermo Fisher Scientific Inc. (U.S.)
  • Creative Diagnostics (U.S.)
  • Abcam PLC (UK)
  • Bio-Rad Laboratories Inc. (U.S.)
  • Kaneka Eurogentec S.A. (Belgium)
  • YenZym Antibodies LLC (U.S.)
  • Abmart (China)
  • Labcorp Drug Development (U.S.)
  • LifeSpan BioSciences Inc. (U.S.)
  • GenScript (U.S.)

Buy this Premium Research Report with Discount | Immediate Delivery @ https://www.vantagemarketresearch.com/buy-now/custom-antibody-market-2201/0

Recent Development of the Global Custom Antibody Market

  • On December 22, 2022, Merck KGaA collaborated with Kelun-Biotech to develop seven investigational preclinical antibody-drug conjugates (ADC) for the treatment of cancer.
  • On July 5, 2022, Bio-Techne acquired Namocell to expand its product portfolio, to include gene therapy development and commercialization, cell engineering, cell line development, single-cell genomics, and antibody discovery.

Browse market data Tables and Figures spread through 144 Pages and in-depth TOC on Custom Antibody Market Forecast Report (2023-2030).

Custom Antibody Market Segmentation
By Type

  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Recombinant Antibodies
  • Other Types

By Service

  • Antibody Assay Development
  • Antibody Production and Development
  • Antibody Labeling
  • Antibody Fragmentation
  • Antibody Purification and Conjugation
  • Antibody Engineering and Modification
  • Other Services

By Source

  • Mice
  • Rabbits
  • Other Sources

By Application

  • Research
  • Diagnostic
  • Therapeutic
  • Other Applications

By End-user

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Diagnostic Laboratories
  • Contract Research Organizations
  • Other End-Users

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Read Full Report with TOC @ https://www.vantagemarketresearch.com/industry-report/custom-antibody-market-2201

Browse More Reports from Vantage Library:       

About Vantage Market Research:

We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies.

Follow Us on: LinkedIn | Twitter | Facebook | YouTube

Contact us

Eric Kunz

6218 Georgia Avenue NW Ste 1 - 564

Washington DC 20011-5125

United States Tel: +1 202 380 9727

Email: sales@vantagemarketresearch.com

Website:

https://www.vantagemarketresearch.com/

Latest Vantage Market Research Press Releases

Latest Vantage Market Research Blog

Vantage Market Research All Reports

Blog:


Tags

Custom Antibody Market Custom Antibody Industry Monoclonal Antibodies Polyclonal Antibodies Recombinant Antibodies

Related Links